Legislative incapacity and underreporting of COVID-19 mortality.

Bureaucracy COVID-19 Executive Legislature

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
May 2024
Historique:
received: 10 01 2024
revised: 16 03 2024
accepted: 17 03 2024
medline: 2 4 2024
pubmed: 2 4 2024
entrez: 2 4 2024
Statut: epublish

Résumé

The prevalent interpretation of COVID-19 mortality underreporting typically focuses on authoritarian regimes' propensity for data manipulation. This study, however, posits that the demand side is integral to enhancing the veracity of COVID-19 mortality figures. Through quantitative analysis, it is demonstrated that legislative oversight of the executive significantly correlates with the divergence between excess mortality and officially reported COVID-19 mortality. Moreover, such oversight is shown to bolster the influence of bureaucratic capacity on the precision of mortality data. Consequently, these findings suggest that the notion of "autocratic advantage" in COVID-19 management is not solely a byproduct of regime-led data falsification but also a reflection of deficiencies in legislative and bureaucratic capacities.

Identifiants

pubmed: 38562433
doi: 10.1016/j.pmedr.2024.102694
pii: S2211-3355(24)00109-8
pmc: PMC10982546
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102694

Informations de copyright

© 2024 Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Takaharu Saito (T)

Nagoya University of Commerce and Business, Japan.

Classifications MeSH